Limits...
Evaluation of the efficacy of 100% Type-I collagen membrane of bovine origin in the treatment of human gingival recession: A clinical study.

Soni N, Sikri P, Kapoor D, Soni BW, Jain R - Indian J Dent (2014)

Bottom Line: Twenty cases of Miller's class I or class II localized gingival recession defects on the facial surface were treated with 100% type I collagen membrane of bovine origin in conjunction with coronally positioned flap.The data thus collected were analyzed statistically.Statistically significant improvement based on Student's t test was found in all the three clinical parameters.

View Article: PubMed Central - PubMed

Affiliation: Department of Periodontology, Gian Sagar Dental College and Hospital, Rajpura, Punjab, India.

ABSTRACT

Background: Various treatment modalities have been devised for gingival recession, which is one of the most common signs of periodontal disease. The present study evaluates the efficacy of bioresorbable 100% type I collagen membrane of bovine origin in the treatment of human gingival recession.

Materials and methods: Twenty cases of Miller's class I or class II localized gingival recession defects on the facial surface were treated with 100% type I collagen membrane of bovine origin in conjunction with coronally positioned flap. Pre-operative and post-operative assessments were performed with respect to probing pocket depth, clinical attachment level and clinical recession at 12, 24 and 36 weeks. The data thus collected were analyzed statistically.

Results: Statistically significant improvement based on Student's t test was found in all the three clinical parameters.

Conclusion: Bioresorbable 100% type I collagen membrane of bovine origin has given inspiring results in the treatment of human gingival recession defects, thereby justifying the use of this material wherever indicated.

No MeSH data available.


Related in: MedlinePlus

The bioresorbable Type-I collagen membrane (Biomend®)
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4213877&req=5

Figure 1: The bioresorbable Type-I collagen membrane (Biomend®)

Mentions: 100% type-I resorbable collagen membrane of bovine origin (BioMend®, Sulzer Calcitek, Carlsbad, CA, USA) was used [Figure 1].


Evaluation of the efficacy of 100% Type-I collagen membrane of bovine origin in the treatment of human gingival recession: A clinical study.

Soni N, Sikri P, Kapoor D, Soni BW, Jain R - Indian J Dent (2014)

The bioresorbable Type-I collagen membrane (Biomend®)
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4213877&req=5

Figure 1: The bioresorbable Type-I collagen membrane (Biomend®)
Mentions: 100% type-I resorbable collagen membrane of bovine origin (BioMend®, Sulzer Calcitek, Carlsbad, CA, USA) was used [Figure 1].

Bottom Line: Twenty cases of Miller's class I or class II localized gingival recession defects on the facial surface were treated with 100% type I collagen membrane of bovine origin in conjunction with coronally positioned flap.The data thus collected were analyzed statistically.Statistically significant improvement based on Student's t test was found in all the three clinical parameters.

View Article: PubMed Central - PubMed

Affiliation: Department of Periodontology, Gian Sagar Dental College and Hospital, Rajpura, Punjab, India.

ABSTRACT

Background: Various treatment modalities have been devised for gingival recession, which is one of the most common signs of periodontal disease. The present study evaluates the efficacy of bioresorbable 100% type I collagen membrane of bovine origin in the treatment of human gingival recession.

Materials and methods: Twenty cases of Miller's class I or class II localized gingival recession defects on the facial surface were treated with 100% type I collagen membrane of bovine origin in conjunction with coronally positioned flap. Pre-operative and post-operative assessments were performed with respect to probing pocket depth, clinical attachment level and clinical recession at 12, 24 and 36 weeks. The data thus collected were analyzed statistically.

Results: Statistically significant improvement based on Student's t test was found in all the three clinical parameters.

Conclusion: Bioresorbable 100% type I collagen membrane of bovine origin has given inspiring results in the treatment of human gingival recession defects, thereby justifying the use of this material wherever indicated.

No MeSH data available.


Related in: MedlinePlus